AlzeCure Pharma
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Hälsovägen 7 Våning 7, Huddinge, Stockho...Phone Number
+46 703020896Website
www.alzecurepharma.seRevenue
$5.4 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About AlzeCure Pharma
AlzeCure Pharma AB is a Swedish pharmaceutical company focused on the research and development of innovative and effective drugs, primarily targeting Alzheimer's disease. The company develops first-in-class symptomatic and disease-modifying treatments for Alzheimer's and other cognitive dysfunction disorders. AlzeCure Pharma aims to address the urgent need for effective therapies in the treatment of Alzheimer's, a life-threatening condition with currently limited treatment options. Their intended clients include patients suffering from Alzheimer's disease and related cognitive disorders.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AlzeCure Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at AlzeCure Pharma
Product Launch: Get notified when AlzeCure Pharma launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on AlzeCure Pharma recently announced quarterly report
AlzeCure Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if AlzeCure Pharma has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once AlzeCure Pharma has new funding data
Check out if AlzeCure Pharma is spiking on competitors!
Click to see if AlzeCure Pharma had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at AlzeCure Pharma
Find 3 more new buyers
Company Profile Activity
Activity Insights
AlzeCure Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AlzeCure Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AlzeCure Pharma.
AlzeCure Pharma Tech Stack
A closer look at the technologies used by AlzeCure Pharma
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Person-Based
AlzeCure Pharma News & Media
AlzeCure Publishes its Interim Report for January - March 2025 - PharmiWeb.com
STOCKHOLM, SE / ACCESS Newswire / May 5, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interim report for the period January - March 2025 is now available on the company's website: www.alzecurepharma.com/en/section/investors/financial-reports/"...AlzeCure Publishes its Interim Report for January – June 2024 - Yahoo Finance
STOCKHOLM, SE / ACCESSWIRE / August 26, 2024 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interim report for the period January - June 2024 is now available on the company's website: ...AlzeCure Publishes its Year-end Report for January - September 2022
AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its Year-end report for the period January - December 2022 is now available on the company's website: www.alzecurepharma.com/en/section/investors/financial-reports/AlzeCure Pharma AB's Chief Scientific Officer has Participated in an Interview ... - Yahoo Finance
AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) ("AlzeCure" or "the Company"), a pharmaceutical company that develops a broad portfolio of small molecule drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced that Erik Penser Bank has published an interview with AlzeCure's Chief Scientific Officer (CSO), Johan Sandin.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding AlzeCure Pharma
Sign Up For FreeTo access detailed company insights
AlzeCure Pharma AB is a Swedish pharmaceutical company focused on the research and development of innovative and effective drugs, primarily targeting Alzheimer's disease. The company develops first-in-class symptomatic and disease-modifying treatments for Alzheimer's and other cognitive dysfunction disorders. AlzeCure Pharma aims to address the urg... Read More
